Home Applications 214783 Application 214783
Type NDA
Sponsor KADMON PHARMA LLC Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 REZUROCK BELUMOSUDIL TABLET;ORAL 200MG No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N214783-001 REZUROCK BELUMOSUDIL MESYLATE EQ 200MG BASE TABLET / ORAL RLD, RS 2021-07-16
Orange Book patents# Current patent rows page 1 of 1 · 7 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N214783-001 10183931 2033-10-07 U-3246 2021-11-17 N214783-001 10183931 2033-10-07 U-4260 2021-11-17 N214783-001 10696660 2033-10-07 U-3246 2021-11-17 N214783-001 10696660 2033-10-07 U-4260 2021-11-17 N214783-001 8357693 2034-06-20 U-4259 Drug substance, Drug product 2021-11-17 N214783-001 11311541 2035-04-09 U-3369 2022-05-25 N214783-001 12097202 2042-07-14 U-4014 2024-10-24
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 2 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N214783-001 NCE 2026-07-16 N214783-001 ODE-362 2028-07-16
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N214783-001 REZUROCK EQ 200MG BASE TABLET / ORAL RLD, RS 2021-07-16 84e616aacf4f…2026-08-18 06:07:40 2026-07 N214783-001 REZUROCK EQ 200MG BASE TABLET / ORAL RLD, RS 2021-07-16 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N214783-001 REZUROCK EQ 200MG BASE TABLET / ORAL RLD, RS 2021-07-16 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214783-001 REZUROCK EQ 200MG BASE TABLET / ORAL RLD, RS 2021-07-16 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N214783-001 REZUROCK EQ 200MG BASE TABLET / ORAL RLD, RS 2021-07-16 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N214783-001 REZUROCK EQ 200MG BASE TABLET / ORAL RLD, RS 2021-07-16 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N214783-001 REZUROCK EQ 200MG BASE TABLET / ORAL RLD, RS 2021-07-16 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N214783-001 REZUROCK EQ 200MG BASE TABLET / ORAL RLD, RS 2021-07-16 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N214783-001 REZUROCK EQ 200MG BASE TABLET / ORAL RLD, RS 2021-07-16 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N214783-001 REZUROCK EQ 200MG BASE TABLET / ORAL RLD, RS 2021-07-16 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N214783-001 REZUROCK EQ 200MG BASE TABLET / ORAL RLD, RS 2021-07-16 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N214783-001 REZUROCK EQ 200MG BASE TABLET / ORAL RLD, RS 2021-07-16 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N214783-001 REZUROCK EQ 200MG BASE TABLET / ORAL RLD, RS 2021-07-16 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N214783-001 REZUROCK EQ 200MG BASE TABLET / ORAL RLD, RS 2021-07-16 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N214783-001 REZUROCK EQ 200MG BASE TABLET / ORAL RLD, RS 2021-07-16 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N214783-001 REZUROCK EQ 200MG BASE TABLET / ORAL RLD, RS 2021-07-16 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N214783-001 REZUROCK EQ 200MG BASE TABLET / ORAL RLD, RS 2021-07-16 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N214783-001 REZUROCK EQ 200MG BASE TABLET / ORAL RLD, RS 2021-07-16 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N214783-001 REZUROCK EQ 200MG BASE TABLET / ORAL RLD, RS 2021-07-16 4b0b4de00fa7…2022-03-09 01:35 UTC 2022-03 N214783-001 REZUROCK EQ 200MG BASE TABLET / ORAL RLD, RS 2021-07-16 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N214783-001 REZUROCK EQ 200MG BASE TABLET / ORAL RLD, RS 2021-07-16 782e0a99824c…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N214783-001 REZUROCK EQ 200MG BASE TABLET / ORAL RLD, RS 2021-07-16 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N214783-001 REZUROCK EQ 200MG BASE TABLET / ORAL RLD, RS 2021-07-16 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N214783-001 REZUROCK EQ 200MG BASE TABLET / ORAL RLD, RS 2021-07-16 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N214783-001 REZUROCK EQ 200MG BASE TABLET / ORAL RLD, RS 2021-07-16 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N214783-001 REZUROCK EQ 200MG BASE TABLET / ORAL RLD, RS 2021-07-16 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N214783-001 REZUROCK EQ 200MG BASE TABLET / ORAL RLD, RS 2021-07-16 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N214783-001 REZUROCK EQ 200MG BASE TABLET / ORAL RLD, RS 2021-07-16 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N214783-001 REZUROCK EQ 200MG BASE TABLET / ORAL RLD, RS 2021-07-16 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N214783-001 REZUROCK EQ 200MG BASE TABLET / ORAL RLD, RS 2021-07-16 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N214783-001 REZUROCK EQ 200MG BASE TABLET / ORAL RLD, RS 2021-07-16 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N214783-001 REZUROCK EQ 200MG BASE TABLET / ORAL RLD, RS 2021-07-16 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N214783-001 REZUROCK EQ 200MG BASE TABLET / ORAL RLD, RS 2021-07-16 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N214783-001 REZUROCK EQ 200MG BASE TABLET / ORAL RLD, RS 2021-07-16 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N214783-001 REZUROCK EQ 200MG BASE TABLET / ORAL RLD, RS 2021-07-16 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 5 · 181 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-09-14 22:38:34 2026-08 N214783-001 10183931 2033-10-07 U-4260 2021-11-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N214783-001 10183931 2033-10-07 U-3246 2021-11-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N214783-001 10696660 2033-10-07 U-4260 2021-11-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N214783-001 10696660 2033-10-07 U-3246 2021-11-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N214783-001 8357693 2034-06-20 U-4259 Drug substance, Drug product 2021-11-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N214783-001 11311541 2035-04-09 U-3369 2022-05-25 84e616aacf4f…2026-09-14 22:38:34 2026-08 N214783-001 12097202 2042-07-14 U-4014 2024-10-24 84e616aacf4f…2026-08-18 06:07:40 2026-07 N214783-001 10183931 2033-10-07 U-4260 2021-11-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N214783-001 10183931 2033-10-07 U-3246 2021-11-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N214783-001 10696660 2033-10-07 U-4260 2021-11-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N214783-001 10696660 2033-10-07 U-3246 2021-11-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N214783-001 8357693 2034-06-20 U-4259 Drug substance, Drug product 2021-11-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N214783-001 11311541 2035-04-09 U-3369 2022-05-25 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N214783-001 12097202 2042-07-14 U-4014 2024-10-24 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N214783-001 10183931 2033-10-07 U-4260 2021-11-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214783-001 10183931 2033-10-07 U-3246 2021-11-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214783-001 10696660 2033-10-07 U-4260 2021-11-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214783-001 10696660 2033-10-07 U-3246 2021-11-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214783-001 8357693 2034-06-20 U-4259 Drug substance, Drug product 2021-11-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214783-001 11311541 2035-04-09 U-3369 2022-05-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214783-001 12097202 2042-07-14 U-4014 2024-10-24 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214783-001 10183931 2033-10-07 U-4260 2021-11-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214783-001 10183931 2033-10-07 U-3246 2021-11-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214783-001 10696660 2033-10-07 U-4260 2021-11-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214783-001 10696660 2033-10-07 U-3246 2021-11-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214783-001 8357693 2034-06-20 U-4259 Drug substance, Drug product 2021-11-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214783-001 11311541 2035-04-09 U-3369 2022-05-25 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214783-001 12097202 2042-07-14 U-4014 2024-10-24 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N214783-001 8357693 2029-10-30 U-3247 Drug substance, Drug product 2021-11-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N214783-001 10183931 2033-10-07 U-3246 2021-11-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N214783-001 10696660 2033-10-07 U-3246 2021-11-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N214783-001 11311541 2035-04-09 U-3369 2022-05-25 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N214783-001 12097202 2042-07-14 U-4014 2024-10-24 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N214783-001 8357693 2029-10-30 U-3247 Drug substance, Drug product 2021-11-17 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N214783-001 10183931 2033-10-07 U-3246 2021-11-17 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N214783-001 10696660 2033-10-07 U-3246 2021-11-17 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N214783-001 11311541 2035-04-09 U-3369 2022-05-25 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N214783-001 12097202 2042-07-14 U-4014 2024-10-24 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N214783-001 8357693 2029-10-30 U-3247 Drug substance, Drug product 2021-11-17 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N214783-001 10183931 2033-10-07 U-3246 2021-11-17 b8a1b40f171c…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 2 · 70 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 3 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 79802-200 Rezurock belumosudil Kadmon Pharmaceuticals, LLC NDA Current 79802-200 Rezurock belumosudil Kadmon Pharmaceuticals, LLC NDA Current 79802-200 Rezurock belumosudil Kadmon Pharmaceuticals, LLC NDA Current
Documents# Document, Submission type, Date table Document Submission type Date 84809 SUPPL 2026-01-21 80793 SUPPL 2025-01-02 80790 SUPPL 2025-01-02 78112 SUPPL 2024-04-12 78109 SUPPL 2024-04-11 76564 SUPPL 2023-11-14 76556 SUPPL 2023-11-13 68370 ORIG 2021-08-13 68135 ORIG 2021-07-20 68114 ORIG 2021-07-19